Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-90.7%
operating margin TTM
-160.65%
revenue TTM
16.79 Million
revenue per share TTM
1.79$
valuation ratios | |
|---|---|
| pe ratio | -0.67 |
| peg ratio | -0.01 |
| price to book ratio | -0.00 |
| price to sales ratio | 0.80 |
| enterprise value multiple | -883.59 |
| price fair value | -0.00 |
profitability ratios | |
|---|---|
| gross profit margin | 96.02% |
| operating profit margin | -160.65% |
| pretax profit margin | -73.38% |
| net profit margin | -90.7% |
| return on assets | -0.09% |
| return on equity | 0.33% |
| return on capital employed | 0.32% |
liquidity ratio | |
|---|---|
| current ratio | 0.58 |
| quick ratio | 0.54 |
| cash ratio | 0.49 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 669,577.05 |
| operating cycle | 669,577.05 |
| days of payables outstanding | 10,072,928.01 |
| cash conversion cycle | -9,403,350.95 |
| receivables turnover | 0.00 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.01 |
| debt equity ratio | -0.01 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | -0.01 |
| interest coverage | -864.80 |
| cash flow to debt ratio | -0.04 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.36 |
| cash per share | 943.14 |
| operating cash flow per share | -0.36 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -0.04 |
| short term coverage ratios | -0.04 |
| capital expenditure coverage ratio | 0.00 |
Frequently Asked Questions
When was the last time Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) reported earnings?
Adamis Pharmaceuticals Corporation (ADMP) published its most recent earnings results on 14-11-2023.
What is Adamis Pharmaceuticals Corporation's current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)'s trailing twelve months ROE is 0.33%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Adamis Pharmaceuticals Corporation (ADMP) currently has a ROA of -0.09%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADMP's net profit margin stand at?
ADMP reported a profit margin of -90.7% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADMP's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.58 in the most recent quarter. The quick ratio stood at 0.54, with a Debt/Eq ratio of -0.01.